Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis

@article{Chen2018PrevalenceAP,
  title={Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis},
  author={Binrui Chen and John J Kim and Yawen Zhang and Lijun Du and Ning Dai},
  journal={Journal of Gastroenterology},
  year={2018},
  volume={53},
  pages={807-818}
}
BackgroundThe reported prevalence of small intestinal bacterial overgrowth (SIBO) among individuals with irritable bowel syndrome (IBS) is highly variable. The aim of the study is to estimate the prevalence and identify predictors of SIBO in IBS.MethodsPubMed, Cochrane Library, and EMBASE through July 2017 were searched to identify studies evaluating the prevalence of SIBO in IBS. The pooled prevalence of SIBO among individuals with IBS and the pooled odds ratio (OR) of SIBO among those with… 

Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.

TLDR
A systematic review and meta-analysis of studies reporting SIBO prevalence in patients with irritable bowel syndrome and controls suggests a link between IBS and SIBO, but the overall quality of the evidence is low.

Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance

TLDR
Findings suggest the potent role of Prevotella in gastrointestinal symptoms between SIBO and IBS-D, thus provide a novel insight into the connection between SI BO and Ibs-D.

Small Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-Analysis.

TLDR
The quality of evidence is low and can be largely attributed to the type of breath test for SIBO diagnosis and clinical heterogeneity, and more appropriately designed studies are required to confirm the link between FD and SIBO.

[Prevalence of small bowel bacterial overgrowth in patients with functional dyspepsia: a meta-analysis].

TLDR
This meta-analysis has demonstrated that SIBO is often associated with FD and is observed in about every third patient with this functional gastrointestinal tract disease.

Factors That Affect Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Pancreatitis: A Systematic Review, Meta-Analysis, and Meta-Regression

TLDR
SIBO complicates 38% of CP with OR of 5.58 indicating a predisposition for this condition, and PEI correlates with SIBO in CP and might play a role in pathophysiology.

Small Intestinal Bacterial Overgrowth and Lactose Malabsorption in Iraqi Patients with Irritable Bowel Syndrome

TLDR
Rifaximin is an effective therapy even at low doses for SIBO and lactose malabsorption is prevalent mostly among diarrheal-IBS patients and those with higher calprotectin level.

Anti-Helicobacter pylori treatment can effectively improve the clinical remission rates of irritable bowel syndrome: a controlled clinical trial meta-analysis

Here we used a meta-analysis of several clinical trials to determine whether anti-Helicobacter pylori therapy has any positive effect on IBS patients. Here we compared the effective clinical

Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review

TLDR
Current studies indicate that rifaximin induces only modest effects on the gut microbiota of patients with IBS-D, suggesting that the efficacy of rifaxin may involve other mechanisms, and further study is needed.

Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia

TLDR
In FD patients, the response to antimicrobial therapy with rifaximin is not influenced by concomitant IBS symptoms, and the symptom score following a standardized nutrient challenge improved significantly.
...

References

SHOWING 1-10 OF 89 REFERENCES

Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis.

Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.

TLDR
This study is the first to estimate the prevalence of SIBO in ibs patients from Romania and finds that rifaximin is effective in treating SI BO in IBS patients and controlled trials are warranted.

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.

  • R. M. LovellA. Ford
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2012

[Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].

TLDR
Almost 41.67% of the IBS-D patients meeting Rome Ⅲ criteria have SIBO, which can be better screened by combining hydrogen and methane in LBT compared with only hydrogen in L BT.

Small Bowel Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: The First Study in Iran

TLDR
There is a positive association between IBS and SIBO and a Placebo-controlled bacterial eradication study is suggested for identifying the role of SIBO in IBS.

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

TLDR
The data do not support an important role for SIBO according to commonly used clinical definitions, in irritable bowel syndrome, however, mildly increased counts of small-bowel bacteria seem to be more common in IBS, and needs further investigation.

Small intestine bacterial overgrowth in patients with irritable bowel syndrome.

TLDR
The results indicate that SIBO is relatively frequent in IBS patients and that execution of a lactulose BT should be encouraged in all these patients, being the only way to make correct diagnosis of SIBO and establish a valid therapeutic treatment.

Study of small intestinal bacterial overgrowth in North Indian patients with irritable bowel syndrome: a case control study.

TLDR
The prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome patients from North India is approximately 11.1%, which is lower than the reported prevalence.

Frequency of Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome and Chronic Non-Specific Diarrhea

TLDR
SIBO was more common in CNSD including D-IBS than other types of IBS and HC, and was commoner in CNSd than HC.
...